Evidence map›Paper›PMID 39289039›Full record

ArticleJournal of neurochemistry2025

Sex-dependent differences in the ability of nicotine to modulate discrimination learning and cognitive flexibility in mice.

Yoshiatsu Aomine, Yuto Shimo, Koki Sakurai, Mayuka Abe, Tom Macpherson, Takaaki Ozawa, Takatoshi Hikida

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yoshiatsu AomineLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0009-0005-1569-8207
Yuto ShimoLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0009-0004-2869-4320
Koki SakuraiLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0001-6952-7749
Mayuka AbeLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0009-0001-3271-9250
Tom MacphersonLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0002-6943-7302
Takaaki OzawaLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0003-3633-7062
Takatoshi HikidaLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.

Funding

Hokuto Foundation for BioscienceInamori FundationInstitute for Protein Research Promotion Program for Frontier Protein ResearchJapan Agency for Medical Research and Development JP21gm1510006Japan Agency for Medical Research and Development JP21wm0425010Japan Agency for Medical Research and Development JP22gm6510012Japan Science and Technology Agency JPMJSP2138Japan Society for the Promotion of Science JP21K15210Japan Society for the Promotion of Science JP21K18557Japan Society for the Promotion of Science JP22H01105Japan Society for the Promotion of Science JP23K18163Japan Society for the Promotion of Science JP23K24205Japan Society for the Promotion of Science JP24KJ1604LOTTE FoundationSalt Science Research Foundation 2341Salt Science Research Foundation 2438SR fundationTakeda Science Foundation
6 · The paper itself

Abstract

Nicotine, an addictive compound found in tobacco, functions as an agonist of nicotinic acetylcholine receptors (nAChRs) in the brain. Interestingly, nicotine has been reported to act as a cognitive enhancer in both human subjects and experimental animals. However, its effects in animal studies have not always been consistent, and sex differences have been identified in the effects of nicotine on several behaviors. Specifically, the role that sex plays in modulating the effects of nicotine on discrimination learning and cognitive flexibility in rodents is still unclear. Here, we evaluated sex-dependent differences in the effect of daily nicotine intraperitoneal (i.p.) administration at various doses (0.125, 0.25, and 0.5 mg/kg) on visual discrimination (VD) learning and reversal (VDR) learning in mice. In male mice, 0.5 mg/kg nicotine significantly improved performance in the VDR, but not the VD, task, while 0.5 mg/kg nicotine significantly worsened performance in the VD, but not VDR task in female mice. Furthermore, 0.25 mg/kg nicotine significantly worsened performance in the VD and VDR task only in female mice. Next, to investigate the cellular mechanisms that underlie the sex difference in the effects of nicotine on cognition, transcriptomic analyses were performed focusing on the medial prefrontal cortex tissue samples from male and female mice that had received continuous administration of nicotine for 3 or 18 days. As a result of pathway enrichment analysis and protein-protein interaction analysis using gene sets of differentially expressed genes, decreased expression of postsynaptic-related genes in males and increased expression of innate immunity-related genes in females were identified as possible molecular mechanisms related to sex differences in the effects of nicotine on cognition in discrimination learning and cognitive flexibility. Our result suggests that nicotine modulates cognitive function in a sex-dependent manner by alternating the expression of specific gene sets in the medial prefrontal cortex.

Indexed as

CognitionDiscrimination LearningNicotineNicotinic AgonistsSex CharacteristicsAnimalsDose-Response Relationship, DrugFemaleMaleMiceMice, Inbred C57BLReversal LearningNicotineNicotinic Agonistscognitive flexibilityprotein–protein interaction networkreversal learningRNA‐seqtranscription factor analysisvisual discrimination learning

Identifiers

PMID39289039
PMCPMC11658186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.